Cargando…
Hypercapnic BOLD MRI compared to H(2)(15)O PET/CT for the hemodynamic evaluation of patients with Moyamoya Disease
BACKGROUND AND PURPOSE: Patients with Moyamoya Disease (MMD) need hemodynamic evaluation of vascular territories at risk of stroke. Today's investigative standards include H(2)(15)O PET/CT with pharmacological challenges with acetazolamide (ACZ). Recent developments suggest that CO(2)-triggered...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370561/ https://www.ncbi.nlm.nih.gov/pubmed/30743136 http://dx.doi.org/10.1016/j.nicl.2019.101713 |
_version_ | 1783394366008590336 |
---|---|
author | Hauser, Till-Karsten Seeger, Achim Bender, Benjamin Klose, Uwe Thurow, Johannes Ernemann, Ulrike Tatagiba, Marcos Meyer, Philipp T. Khan, Nadia Roder, Constantin |
author_facet | Hauser, Till-Karsten Seeger, Achim Bender, Benjamin Klose, Uwe Thurow, Johannes Ernemann, Ulrike Tatagiba, Marcos Meyer, Philipp T. Khan, Nadia Roder, Constantin |
author_sort | Hauser, Till-Karsten |
collection | PubMed |
description | BACKGROUND AND PURPOSE: Patients with Moyamoya Disease (MMD) need hemodynamic evaluation of vascular territories at risk of stroke. Today's investigative standards include H(2)(15)O PET/CT with pharmacological challenges with acetazolamide (ACZ). Recent developments suggest that CO(2)-triggered blood‑oxygen-level-dependent (BOLD) functional MRI might provide comparable results to current standard methods for evaluation of territorial hemodynamics, while being a more widely available and easily implementable method. This study examines results of a newly developed quantifiable analysis algorithm for CO(2)-triggered BOLD MRI in Moyamoya patients and correlates the results with H(2)(15)O PET/CT with ACZ challenge to assess comparability between both modalities. METHODS: CO(2)-triggered BOLD MRI was performed and compared to H(2)(15)O PET/CT with ACZ challenge in patients with angiographically proven MMD. Images of both modalities were analyzed retrospectively in a blinded, standardized fashion by visual inspection, as well as with a semi-quantitative analysis using stimuli-induced approximated regional perfusion-weighted data and BOLD-signal changes with reference to cerebellum. RESULTS: 20 consecutive patients fulfilled the inclusion criteria, a total of 160 vascular territories were analyzed retrospectively. Visual analysis (4-step visual rating system) of standardized, color-coded cerebrovascular reserve/reactivity maps showed a very strong correlation (Spearman's rho = 0.9, P < 0.001) between both modalities. Likewise, comparison of approximated regional perfusion changes across vascular territories (normalized to cerebellar change) reveal a highly significant correlation between both methods (Pearson's r = 0.71, P < 0.001). CONCLUSIONS: The present analysis indicates that CO(2)-triggered BOLD MRI is a very promising tool for the hemodynamic evaluation of MMD patients with results comparable to those seen in H(2)(15)O PET/CT with ACZ challenge. It therefore holds future potential in becoming a routine examination in the pre- and postoperative evaluation of MMD patients after further prospective evaluation. |
format | Online Article Text |
id | pubmed-6370561 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-63705612019-02-21 Hypercapnic BOLD MRI compared to H(2)(15)O PET/CT for the hemodynamic evaluation of patients with Moyamoya Disease Hauser, Till-Karsten Seeger, Achim Bender, Benjamin Klose, Uwe Thurow, Johannes Ernemann, Ulrike Tatagiba, Marcos Meyer, Philipp T. Khan, Nadia Roder, Constantin Neuroimage Clin Regular Article BACKGROUND AND PURPOSE: Patients with Moyamoya Disease (MMD) need hemodynamic evaluation of vascular territories at risk of stroke. Today's investigative standards include H(2)(15)O PET/CT with pharmacological challenges with acetazolamide (ACZ). Recent developments suggest that CO(2)-triggered blood‑oxygen-level-dependent (BOLD) functional MRI might provide comparable results to current standard methods for evaluation of territorial hemodynamics, while being a more widely available and easily implementable method. This study examines results of a newly developed quantifiable analysis algorithm for CO(2)-triggered BOLD MRI in Moyamoya patients and correlates the results with H(2)(15)O PET/CT with ACZ challenge to assess comparability between both modalities. METHODS: CO(2)-triggered BOLD MRI was performed and compared to H(2)(15)O PET/CT with ACZ challenge in patients with angiographically proven MMD. Images of both modalities were analyzed retrospectively in a blinded, standardized fashion by visual inspection, as well as with a semi-quantitative analysis using stimuli-induced approximated regional perfusion-weighted data and BOLD-signal changes with reference to cerebellum. RESULTS: 20 consecutive patients fulfilled the inclusion criteria, a total of 160 vascular territories were analyzed retrospectively. Visual analysis (4-step visual rating system) of standardized, color-coded cerebrovascular reserve/reactivity maps showed a very strong correlation (Spearman's rho = 0.9, P < 0.001) between both modalities. Likewise, comparison of approximated regional perfusion changes across vascular territories (normalized to cerebellar change) reveal a highly significant correlation between both methods (Pearson's r = 0.71, P < 0.001). CONCLUSIONS: The present analysis indicates that CO(2)-triggered BOLD MRI is a very promising tool for the hemodynamic evaluation of MMD patients with results comparable to those seen in H(2)(15)O PET/CT with ACZ challenge. It therefore holds future potential in becoming a routine examination in the pre- and postoperative evaluation of MMD patients after further prospective evaluation. Elsevier 2019-02-04 /pmc/articles/PMC6370561/ /pubmed/30743136 http://dx.doi.org/10.1016/j.nicl.2019.101713 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Regular Article Hauser, Till-Karsten Seeger, Achim Bender, Benjamin Klose, Uwe Thurow, Johannes Ernemann, Ulrike Tatagiba, Marcos Meyer, Philipp T. Khan, Nadia Roder, Constantin Hypercapnic BOLD MRI compared to H(2)(15)O PET/CT for the hemodynamic evaluation of patients with Moyamoya Disease |
title | Hypercapnic BOLD MRI compared to H(2)(15)O PET/CT for the hemodynamic evaluation of patients with Moyamoya Disease |
title_full | Hypercapnic BOLD MRI compared to H(2)(15)O PET/CT for the hemodynamic evaluation of patients with Moyamoya Disease |
title_fullStr | Hypercapnic BOLD MRI compared to H(2)(15)O PET/CT for the hemodynamic evaluation of patients with Moyamoya Disease |
title_full_unstemmed | Hypercapnic BOLD MRI compared to H(2)(15)O PET/CT for the hemodynamic evaluation of patients with Moyamoya Disease |
title_short | Hypercapnic BOLD MRI compared to H(2)(15)O PET/CT for the hemodynamic evaluation of patients with Moyamoya Disease |
title_sort | hypercapnic bold mri compared to h(2)(15)o pet/ct for the hemodynamic evaluation of patients with moyamoya disease |
topic | Regular Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6370561/ https://www.ncbi.nlm.nih.gov/pubmed/30743136 http://dx.doi.org/10.1016/j.nicl.2019.101713 |
work_keys_str_mv | AT hausertillkarsten hypercapnicboldmricomparedtoh215opetctforthehemodynamicevaluationofpatientswithmoyamoyadisease AT seegerachim hypercapnicboldmricomparedtoh215opetctforthehemodynamicevaluationofpatientswithmoyamoyadisease AT benderbenjamin hypercapnicboldmricomparedtoh215opetctforthehemodynamicevaluationofpatientswithmoyamoyadisease AT kloseuwe hypercapnicboldmricomparedtoh215opetctforthehemodynamicevaluationofpatientswithmoyamoyadisease AT thurowjohannes hypercapnicboldmricomparedtoh215opetctforthehemodynamicevaluationofpatientswithmoyamoyadisease AT ernemannulrike hypercapnicboldmricomparedtoh215opetctforthehemodynamicevaluationofpatientswithmoyamoyadisease AT tatagibamarcos hypercapnicboldmricomparedtoh215opetctforthehemodynamicevaluationofpatientswithmoyamoyadisease AT meyerphilippt hypercapnicboldmricomparedtoh215opetctforthehemodynamicevaluationofpatientswithmoyamoyadisease AT khannadia hypercapnicboldmricomparedtoh215opetctforthehemodynamicevaluationofpatientswithmoyamoyadisease AT roderconstantin hypercapnicboldmricomparedtoh215opetctforthehemodynamicevaluationofpatientswithmoyamoyadisease |